The American Association of Colleges of Nursing will award 1.5 contact hours of continuing education (up to a total of 15 hours for the entire Bench to Bedside series) for viewing this tape/CD-ROM as an educational activity. This Continuing Education Credit (CEC) Form must be submitted to verify you viewed the tape/CD-ROM and earned the credit.
Steps
1. Print this copy of the Continuing Education Credit Form
2. View the videotape or CD-ROM
3. Complete all information requested
4. Copy the completed form for your records of contact hours earned. No additional verification will be sent to you.
5. Send original copy of completed form to: CenterNet/HMTV, 529 14th Street, N.W., Suite 1292, Washington, DC 20045
Recombinant Immunotoxin Therapy of
Cancer is part of the Bench to Bedside Video/CD-ROM Series for clinicians.
At the conclusion of this activity, the learner will be able to:
Identify two monoclonal antibodies now being used to treat cancer
Describe why it is often necessary to attach a toxic substance to an
antibody
Understand the composition and basic structure of a recombinant immunotoxin.
Be aware of which diseases have malignant cells which display surface CD22
or CD25 and which of these have responded best to recombinant immunotoxins
Describe immunotoxin structure and composition
Describe the pathway of immunotoxin killing of cancer cell.e
(Please print)
Name________________________________________________ RN License # and
state______________________
(Last)
(M.I.)
(First)
Address______________________________________________ City/State/Zip_____________________________
Date tape viewed______________ CE form printed on: Signature _____________________________
1.
Relationship to program purpose.
Learning objectives for Recombinant Immunotoxin Therapy of Cancer
support the overall purpose for which the series is designed.
___Yes ___Partially ___No
2. Objectives
Has this program enabled you to have a better
understanding of the objectives listed above:
___Yes ___Partially ___No
3. Presenters
Please rate effectiveness of each presenter:
| Ira Pastan, M.D. | _____Somewhat Effective | _____Effective | _____Very Effective |
| Robert J. Kreitman, M.D. | _____Somewhat Effective | _____Effective | _____Very Effective |
| David Fitzgerald, Ph.D. | _____Somewhat Effective | _____Effective | _____Very Effective |
4.
Overall Program
Overall this educational activity was: _____Marginal _____Good _____Excellent
Comments: